News

Sysmex America was also awarded a three-year sole-source hematology agreement for Premier’s Accelerated Supply Chain Endeavor (ASCEND) program member-participants. ASCEND helps Premier members achieve sustained improvement in supply

The compounds are functionally liver-selective Glucokinase Activators (GKAs), which represent a novel class of glucose-lowering agents for the treatment of diabetes. Through the license agreement, Forest is expected

Astellas has completed the acquisition of OSI through a short-form merger without a meeting of OSI’s stockholders. In the merger, each outstanding share of OSI common stock not

Discovery Labs claimed that if approved, Surfaxin would be the first synthetic, peptide-containing surfactant for commercial use in neonatal medicine. Discovery Labs plans to submit its complete response

Almac IXRS 2.0 smart menu technology presents users with valid options and guides them to correct choices, directing their workflow in a logical and intuitive manner. According to

Novacta Biosystems, a UK-based biotechnology company controlled by Celtic Pharma, is focused on bringing new and modern anti infective therapies to the market. DSM it has completed the

Reportedly, the pivotal, international, multicenter Phase III clinical trial, called Admyre, is expected to enroll 300 patients in 60 medical centers across 20 countries (including the US, Europe,

Absorption Systems said that the services offer enhanced value across three critical elements: robust assay designs, timely project execution and data interpretation focused on the advancement potential of

APP Pharma is a pharmaceutical company that develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. APP